Comparison Between Maternal Complications of Chromic Catgut and Vicryl Rapid Sutures Used for Episiotomy Repair
NCT ID: NCT07073131
Last Updated: 2025-07-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
202 participants
INTERVENTIONAL
2024-07-01
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Closing Uterine Incision During C-section Using Barbed Suture (Stratafix) or Vicryl Suture.
NCT03159871
Efficacy of Triclosan-coated Sutures in the Episiotomy
NCT02847936
Comparison of Episiotomy Scissors and BasIQ-4 Episiotomy Device in Mediolateral Episiotomy
NCT04696796
Prospective Randomized Trial On Episiorrhaphy
NCT07045285
The Impact of Different Skin Suture Methods in Episiotomy Repair on Healing and Pain
NCT06379048
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Participants with Vicryl Rapide suturing
After approval from ethical review board (ERC letter no: 37-2024 dated 10-01-2024), 202 females fulfilling the selection criteria were enrolled from labor room. Informed consent was taken. Demographics were noted. Then participants underwent episiotomy. At end of procedure, they were randomly divided in two groups by using lottery method. Group A includes 101 participants that underwent suturing by using vicryl rapide. After 24 hours they were examined for pain score by using visual analogue scale. They were discharged after examining the episiotomy wound and were followed-up for 7 days in OPD. During follow-up, participants were examined for pain score, wound infection, inflammation and dehiscence.
Vicryl Rapide suturing
Post episiotomy vicryl rapide suturing material is used for stitching episiotomy laceration.
Participants with chromic catgut suturing
Total 202 females fulfilling the selection criteria were enrolled from labor room. Informed consent was taken. Demographics were noted. Then participants underwent episiotomy. At end of procedure, they were randomly divided in two groups by using lottery method. Group B included 101 participants that underwent suturing by using chromic catgut. After 24 hours they were examined for pain score by using visual analogue scale. They were discharged after examining the episiotomy wound and were followed-up for 7 days in OPD. During follow-up, participants were examined for pain score, wound infection, inflammation and dehiscence.
Chromic catgut suturing
Post episiotomy chromic catgut suturing material is used for stitching episiotomy laceration
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vicryl Rapide suturing
Post episiotomy vicryl rapide suturing material is used for stitching episiotomy laceration.
Chromic catgut suturing
Post episiotomy chromic catgut suturing material is used for stitching episiotomy laceration
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Gestational age during 37-40 weeks
Exclusion Criteria
* pre-delivery hemoglobin \<9 g/dl,
* Manual removal of placenta
* Vulvar hematoma and vaginal tears
18 Years
35 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Huma Ijaz
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Huma Ijaz
Dr Huma Ijaz
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CMH Gujranwala
Chak One Hundred Seventy-five Nine Left, Punjab Province, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
37
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.